Literature DB >> 11741902

ATP binding to the first nucleotide-binding domain of multidrug resistance protein MRP1 increases binding and hydrolysis of ATP and trapping of ADP at the second domain.

Yue-xian Hou1, Liying Cui, John R Riordan, Xiu-bao Chang.   

Abstract

Multidrug resistance protein (MRP1) utilizes two non-equivalent nucleotide-binding domains (NBDs) to bind and hydrolyze ATP. ATP hydrolysis by either one or both NBDs is essential to drive transport of solute. Mutations of either NBD1 or NBD2 reduce solute transport, but do not abolish it completely. How events at these two domains are coordinated during the transport cycle have not been fully elucidated. Earlier reports (Gao, M., Cui, H. R., Loe, D. W., Grant, C. E., Almquist, K. C., Cole, S. P., and Deeley, R. G. (2000) J. Biol. Chem. 275, 13098-13108; Hou, Y., Cui, L., Riordan, J. R., and Chang, X. (2000) J. Biol. Chem. 275, 20280-20287) indicate that intact ATP is observed bound at NBD1, whereas trapping of the ATP hydrolysis product, ADP, occurs predominantly at NBD2 and that trapping of ADP at NBD2 enhances ATP binding at NBD1 severalfold. This suggested transmission of a positive allosteric interaction from NBD2 to NBD1. To assess whether ATP binding at NBD1 can enhance the trapping of ADP at NBD2, photoaffinity labeling experiments with [alpha-(32)P]8-N(3)ADP were performed and revealed that when presented with this compound labeling of MRP1 occurred at both NBDs. However, upon addition of ATP, this labeling was enhanced 4-fold mainly at NBD2. Furthermore, the nonhydrolyzable ATP analogue, 5'-adenylylimidodiphosphate (AMP-PNP), bound preferentially to NBD1, but upon addition of a low concentration of 8-N(3)ATP, the binding at NBD2 increased severalfold. This suggested that the positive allosteric stimulation from NBD1 actually involves an increase in ATP binding at NBD2 and hydrolysis there leading to the trapping of ADP. Mutations of Walker A or B motifs in either NBD greatly reduced their ability to be labeled by [alpha-(32)P]8-N(3)ADP as well as by either [alpha-(32)P]- or [gamma-(32)P]8-N(3)ATP (Hou et al. (2000), see above). These mutations also strongly diminished the enhancement by ATP of [alpha-(32)P]8-N(3)ADP labeling and the transport activity of the protein. Taken together, these results demonstrate directly that events at NBD1 positively influence those at NBD2. The interactions between the two asymmetric NBDs of MRP1 protein may enhance the catalytic efficiency of the MRP1 protein and hence of its ATP-dependent transport of conjugated anions out of cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11741902     DOI: 10.1074/jbc.M107133200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

2.  Glutamine residues in Q-loops of multidrug resistance protein MRP1 contribute to ATP binding via interaction with metal cofactor.

Authors:  Runying Yang; Yue-xian Hou; Chase A Campbell; Kanagaraj Palaniyandi; Qing Zhao; Andrew J Bordner; Xiu-bao Chang
Journal:  Biochim Biophys Acta       Date:  2011-02-26

3.  Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: long-lived NO that is trafficked by interacting proteins.

Authors:  Yohan Suryo Rahmanto; Danuta S Kalinowski; Darius J R Lane; Hiu Chuen Lok; Vera Richardson; Des R Richardson
Journal:  J Biol Chem       Date:  2012-01-19       Impact factor: 5.157

4.  Hydrogen-bond formation of the residue in H-loop of the nucleotide binding domain 2 with the ATP in this site and/or other residues of multidrug resistance protein MRP1 plays a crucial role during ATP-dependent solute transport.

Authors:  Runying Yang; Xiu-bao Chang
Journal:  Biochim Biophys Acta       Date:  2006-11-18

5.  Asymmetric ATP hydrolysis cycle of the heterodimeric multidrug ABC transport complex TmrAB from Thermus thermophilus.

Authors:  Ariane Zutz; Jan Hoffmann; Ute A Hellmich; Clemens Glaubitz; Bernd Ludwig; Bernd Brutschy; Robert Tampé
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

6.  Nucleotide binding to the human multidrug resistance protein 3, MRP3.

Authors:  Andrea D Hoffman; Ina L Urbatsch; Pia D Vogel
Journal:  Protein J       Date:  2010-07       Impact factor: 2.371

7.  Boosted coupling of ATP hydrolysis to substrate transport upon cooperative estradiol-17-β-D-glucuronide binding in a Drosophila ATP binding cassette type-C transporter.

Authors:  Agnes Karasik; Kaitlyn Victoria Ledwitch; Tamás Arányi; András Váradi; Arthur Roberts; Flóra Szeri
Journal:  FASEB J       Date:  2018-01-04       Impact factor: 5.191

8.  Identification of a novel 2026G-->C mutation of the MRP2 gene in a Japanese patient with Dubin-Johnson syndrome.

Authors:  Shinya Wakusawa; Ikuo Machida; Satoshi Suzuki; Hisao Hayashi; Motoyoshi Yano; Kentaro Yoshioka
Journal:  J Hum Genet       Date:  2003-07-22       Impact factor: 3.172

9.  Nucleotides and transported substrates modulate different steps of the ATPase catalytic cycle of MRP1 multidrug transporter.

Authors:  András Kern; Zsófia Szentpétery; Károly Liliom; Eva Bakos; Balázs Sarkadi; András Váradi
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

10.  Characterization of an asymmetric occluded state of P-glycoprotein with two bound nucleotides: implications for catalysis.

Authors:  Alena Siarheyeva; Ronghua Liu; Frances J Sharom
Journal:  J Biol Chem       Date:  2010-01-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.